36 results
8-K
EX-10.2
ATXI
Avenue Therapeutics, Inc.
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure
424B4
b6ngtke 8xzff
11 Oct 22
Prospectus supplement with pricing info
8:27am
DEFM14A
3ephh 13cvx
21 Dec 18
Proxy related to merger
12:23pm
PREM14A
166 pqshsx5aoyhf86b
11 Dec 18
Preliminary proxy related to merger
5:23pm